Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8158601 Lipid formulation

Patent 8158601 was granted and assigned to Alnylam Pharmaceuticals on April, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Current Assignee

Alnylam Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Jianxin Chen0

Xiaojun Qin0

Akin Akinc0

Jayaprakash K. Narayanannair0

Joseph Robert Dorkin0

Kallanthottathil G. Rajeev0

Muthiah Manoharan0

Muthusamy Jayaraman0

...

Date of Patent

April 17, 2012

Patent Application Number

12813448

Date Filed

June 10, 2010

Patent Citations Received

US Patent 12129467 Non-liposomal systems for nucleic acid delivery

0

0

US Patent 12060381 Methods for purification of messenger RNA

0

US Patent 12065396 Lipids for use in lipid nanoparticle formulations

0

US Patent 12070509 Nucleic acids and methods of treatment for cystic fibrosis

0

US Patent 12070495 HIV RNA vaccines

0

US Patent 12077501 Compounds and compositions for intracellular delivery of agents

0

US Patent 12084702 Methods for purification of messenger RNA

0

...

Patent Primary Examiner

Tracy Vivlemore

Patent abstract

The invention features a cationic lipid of formula I,

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8158601 Lipid formulation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool